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Abstract: While air pollution has been associated with health complications, its effect on sepsis risk
is unknown. We examined the association between fine particulate matter (PM2.5) air pollution
and risk of sepsis hospitalization. We analyzed data from the 30,239 community-dwelling adults
in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort linked with
satellite-derived measures of PM2.5 data. We defined sepsis as a hospital admission for a serious
infection with ≥2 systemic inflammatory response (SIRS) criteria. We performed incidence density
sampling to match sepsis cases with 4 controls by age (±5 years), sex, and race. For each matched
group we calculated mean daily PM2.5 exposures for short-term (30-day) and long-term (one-year)
periods preceding the sepsis event. We used conditional logistic regression to evaluate the association
between PM2.5 exposure and sepsis, adjusting for education, income, region, temperature, urbanicity,
tobacco and alcohol use, and medical conditions. We matched 1386 sepsis cases with 5544 non-sepsis
controls. Mean 30-day PM2.5 exposure levels (Cases 12.44 vs. Controls 12.34 µg/m3; p = 0.28) and
mean one-year PM2.5 exposure levels (Cases 12.53 vs. Controls 12.50 µg/m3; p = 0.66) were similar
between cases and controls. In adjusted models, there were no associations between 30-day PM2.5
exposure levels and sepsis (4th vs. 1st quartiles OR: 1.06, 95% CI: 0.85–1.32). Similarly, there were no
associations between one-year PM2.5 exposure levels and sepsis risk (4th vs. 1st quartiles OR: 0.96,
95% CI: 0.78–1.18). In the REGARDS cohort, PM2.5 air pollution exposure was not associated with
risk of sepsis.
Keywords: sepsis; air pollution; particulate matter
1. Background
Sepsis is a dangerous syndrome of systemic inflammation triggered by microbial infection such
as pneumonia, kidney infection, cellulitis, and meningitis [1]. Sepsis may rapidly lead to organ
injury, shock, and death. Sepsis is a major threat to U.S. community health, resulting in over 750,000
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hospitalizations and 215,000 deaths in the USA annually—more than from acute myocardial infarction,
lung cancer, or breast cancer [2].
Environmental exposures such as PM2.5 (fine particulate matter with diameter equal to or
smaller than 2.5 µm) have been associated with a host of health risks including increased rates of
cardiovascular disease, pneumonia, asthma, stroke, and all-cause mortality [3–9]. There are plausible
connections between environmental exposures and sepsis risk. Inflammation and vascular endothelial
dysfunction are prominent in sepsis [10]. PM2.5 directly enters the bloodstream, causing similar
systemic inflammation and vascular damage [4]. Prior research links long-term PM2.5 exposure with a
2.3-fold increased pneumonia hospitalization risk [7]. Of note, using U.S. vital statistics, we observed
there to be a belt of states located in the Southeastern USA “belt” with a more than two-fold increased
risk of sepsis mortality [11].
To date, no studies have examined whether long-term exposure to PM2.5 is associated with
increased risk of sepsis. The objective of this study was to determine whether short- or long-term
exposure to PM2.5 is associated with the incidence of sepsis in a large national community-
dwelling cohort.
2. Methods
2.1. Study Design
We performed a nested case-control study within the Reasons for Geographic and Racial
Differences in Stroke (REGARDS) cohort, an ongoing national longitudinal cohort. This study was
approved by the University of Alabama at Birmingham Institutional Review Board (UAB IRB
protocol X090531004).
2.2. Data Source
Designed to evaluate factors associated with racial and geographic differences in stroke mortality,
the REGARDS cohort consists of 30,239 community-dwelling adults aged ≥45 years at baseline [12].
Among REGARDS participants, approximately 45% are male, 41% are black, and 69% are aged
>60 years. REGARDS recruited participants between January 2003 and October 2007. At six-month
intervals, REGARDS contacts participants by telephone to identify any hospitalizations. Further details
for the REGARDS study methods are described elsewhere [13].
2.3. Selection of Sepsis Cases
The primary exposure in this study was defined as first hospitalization for sepsis between
1 January 2003 and 31 December 2011. Using the taxonomy of Angus et al., we identified all
hospitalizations (Emergency Department visits and/or hospital admission) attributed by participants
to a serious infection [2,14]. We defined sepsis cases as hospital admission for a serious infection with
the presence of at least two Systemic Inflammatory Response Syndrome (SIRS) criteria. The SIRS criteria
included: (1) heart rate >90 beats/min; (2) fever (temperature >38.3 ◦C or <36.0 ◦C); (3) tachypnea
(>20 breaths/min) or PCO2 <32 mmHg; and (4) leukocytosis or leukopenia (white blood cells >12,000
or <4000 cells/mm3 or >10% band forms) [13,15]. Since our study focused on community-acquired
(vs. hospital-acquired) sepsis, we used vital signs and laboratory test results for the initial 28 h of
hospitalization. Two trained reviewers evaluated information from the corresponding medical record,
confirming the presence of a serious infection based upon diagnoses documented in the Emergency
Department or admission physician record. Inter-rater agreement for infection (k = 0.92) and presence
of sepsis (k = 0.90) upon hospital presentation was excellent. Discordances were adjudicated among
abstractors, with additional physician review as needed.
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2.4. Selection of Matched Controls
We performed incidence density sampling matching of 1533 sepsis cases with (6132 non-sepsis
controls by age (±5 years), sex, and race (Figure 1). The incidence density sampling method matched
each sepsis case with four controls based upon the sepsis case event date. Controls were participants
that were alive for at least the same time preceding the sepsis case event but without a sepsis event
or death. For example, if a sepsis case event were on 31 January 2008 this sepsis case was matched
with four controls (of similar age (±5 years), sex, and race) from the entire study cohort that had not
died, dropped out, or had a sepsis event up to that date. This matching prevents large imbalance of
cases versus controls and optimizes the statistical efficiency by controlling for possible confounding
(i.e., age, sex, race) [16]. Cases and controls were selected with replacement; sepsis cases could also be
selected as a matched control for another sepsis cases during their time preceding their sepsis event.
In addition, non-sepsis controls could serve as a matched control for more than one sepsis case.
2.5. Measurement of Exposure (PM2.5)
The primary exposures of interest were average prior 30-day and one-year daily PM2.5 for the
residence of each REGARDS participant. We followed the method of Al-Hamdan et al., generating
continuous spatial surfaces of daily PM2.5 on a 10-km grid for the entire contiguous US for years
2003 through 2011 [17]. These data were derived from the U.S. Environmental Protection Agency Air
Quality System (AQS) and the NASA Moderate Resolution Imaging Spectrometer (MODIS) instrument
onboard the Aqua Earth-orbiting satellite. Leveraging NASA MODIS-derived data to complement U.S.
EPA ground observation data, Al-Hamdan et al. estimated daily PM2.5 concentrations using regional
spatial surfacing algorithm, which included regression models, a B-spline smoothing model, a quality
control procedure for the EPA AQS data and a bias adjustment procedure for MODIS/Aerosol Optical
Depth-derived PM2.5 data [17,18]. The surfacing algorithm resulted in continuous spatial surfaces of
daily PM2.5 on a 10-km grid for the contiguous USA from the combination of AQS PM2.5 measurements
and the MODIS-estimated PM2.5. Merging MODIS remote sensing data with surface observations
of PM2.5 not only provided a more complete daily representation of PM2.5 than either dataset alone
would allow, but it also reduced the errors in the PM2.5-estimated surfaces [17,18].
We estimated daily PM2.5 concentrations for the geocoded location of REGARDS participants from
January 2003 through December 2011. We then estimated the 30-day and one-year daily mean PM2.5
concentrations preceding the matched sepsis event date (days leading up to the matched sepsis event
date). We excluded subjects where exposure data were not available prior to REGARDS enrollment.
For statistical analyses, we categorized both 30-day and one-year PM2.5 as a categorical variable by
quartiles and we standardized using the standard deviation of the study population.
2.6. Participant Characteristics
Participant characteristics used in the analysis included self-reported age, race, sex, income,
education, and geographic location. Health behaviors included tobacco (defined as current, past and
never) and alcohol use. We defined alcohol use as moderate (one drink per day for women or two
drinks per day for men) and heavy alcohol use (>1 drink per day for women and >2 drinks per day for
men), per the National Institute on Alcohol Abuse and Alcoholism classification [15].
We included atrial fibrillation, chronic lung disease, coronary artery disease, deep vein thrombosis,
diabetes, dyslipidemia, hypertension, myocardial infarction, obesity, peripheral artery disease,
and stroke as baseline medical conditions. We defined atrial fibrillation by participant self-report
or baseline electrocardiogram (ECG) evidence of an atrial fibrillation event. We defined chronic
lung disease as participants with a history of prescribed pulmonary medication. We classified
coronary artery disease in participants with a history of heart disease (self-reported myocardial
infarction, coronary artery bypass graft, bypass, angioplasty, or stent) or ECG evidence. We defined
diabetes as a fasting glucose ≥126 mg/L (or a glucose ≥200 mg/L for those not fasting) or the use of
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insulin or oral hypoglycemic agents. We categorized dyslipidemia in participants with low-density
lipoprotein cholesterol >130 mg/dL, or use of lipid lowering medications. We defined hypertension as
a systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or the reported use of
antihypertensive agents. We defined myocardial infarction (MI) in participants by ECG evidence or
self-reports of MI in participants’ history. Obesity was defined as a body mass index (BMI) of greater
than or equal to 30 kg/m2 in addition to a gender specific waist circumference [17].
REGARDS did not collect information on pulmonary conditions such as asthma and chronic
obstructive pulmonary disease. Therefore, we defined participant use of pulmonary medications
as a proxy for chronic lung disease. Obtained from each participant’s medication inventory,
pulmonary medications included beta-2 adrenergic agonists, leukotriene inhibitors, inhaled
corticosteroids, combination inhalers, and other pulmonary medications such as ipratropium,
cromolyn, aminophylline, and theophylline. Other medical conditions such as; deep vein thrombosis,
peripheral artery disease, and stroke were based upon self-reports. Detailed definitions of participant
characteristics are described in Appendix A Table A1.
2.7. Community Characteristics
Community characteristics analyzed in this study included season and urbanicity. We
defined season based on the REGARDS participants’ baseline interview date. We categorized
participants’ baseline season using meteorological definitions for spring (1 March–31 May), summer
(1 June–31 August), fall (1 September–30 November), and winter (1 December–28 or 29 February) [19].
This method also allows for an even distribution of calendar days per season [19]. We identified the
urbanicity of each participant’s baseline residence using the county-level proportion of population that
lived in an urban area using data from the 2010 American Community Survey (ACS). The 2010 ACS
is five-year aggregated (2006–2010) data based on a representative sample of non-institutionalized
US residents [20]. The 2010 ACS defined urbanicity based on the primary Rural-Urban Commuting
Area (RUCA) codes (10-tier classification system). The 10 RUCA code classification system was
dichotomized into (1) urban (i.e., population centers with 50,000 or more residents) and (2) non-urban
(i.e., towns or small cities with population centers with less than 50,000 residents [21,22]. Based on the
proportion of residents living in urban counties we then categorized REGARDS participants as living
in either a rural (≤25% urban population), mixed (25–75% urban population), or urban county (≥75%
urban population).
2.8. Statistical Analysis
We compared baseline sociodemographic, community characteristics, health behaviors,
and chronic medical conditions between sepsis cases and non-sepsis controls using conditional logistic
regression for categorical variables and paired t-test for continuous variables. We fit two different
models to examine association between preceding 30-day mean and one-year mean PM2.5 and the odds
of sepsis, separately. First, we evaluated the associations between preceding 30-day mean PM2.5 and
development of sepsis using conditional logistic regression, categorizing the preceding 30-day mean
PM2.5 per standard deviation. Secondly, we evaluated the associations between preceding 30-day mean
PM2.5 and development of sepsis using conditional logistic regression, categorizing the preceding
30-day mean PM2.5 as quartiles with the first quartile as the referent group. We fitted similar models
to examine the associations between one-year mean PM2.5 and the future development of sepsis.
We sequentially adjusted the models for variables observed to be statistically different on bivariate
analysis, including: (1) sociodemographic and environmental variables (i.e., education, income, region,
temperature, and urbanicity); (2) health behaviors (tobacco and alcohol use); and (3) baseline medical
conditions. We performed statistical analysis using SAS version 9.4 and STATA version 13.
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3. Results
Among the 30,239 REGARDS participants, we created a 4:1 matched cohort consisting of
1533 sepsis cases and 6132 non-sepsis controls (Figure 1).
Figure 1. Breakdown of REGARDS participants used in nested case-control study for the association
between short-term PM2.5 exposure and sepsis.
We excluded observations with sepsis case matched dates before 30 January 2003 and after
31 December 2011 due to unavailable PM2.5 daily estimates. For the 30-day exposure analysis,
we included 1386 cases and 5544 non-sepsis controls. For the one-year exposure analysis, we included
1370 cases and 5480 non-sepsis controls.
Compared with the 5544 non-sepsis controls, sepsis cases had lower education and income, were
more likely to be smokers, and were more likely to have a number of comorbidities at baseline (Table 1).
Table 1. Comparison of demographic, substance use, and comorbidity characteristics between sepsis
cases and controls. Among 1386 sepsis cases and 5544 controls matched on age (±5 years), race,
and sex.
Sepsis Cases (n =1386) Non-Sepsis Controls * (n = 5544) p Value **
Age † 68.2 (9.3) 67.9 (9.1) -
Sex (%)
Male 714 (51.5) 2856 (51.5) -
Female 672 (48.5) 2688 (48.5)
Race (%)
Black 463 (33.4) 1852 (33.4) -
White 923 (66.6) 3692 (66.6)
< High School Education (%) 231 (16.7) 580 (10.5) <0.01
Income≤ $20 000 (%) 332 (24.0) 872 (15.7) <0.01
Geographic Region (%)
Stroke Belt a 527 (38.0) 1833 (33.1) <0.01
Buckle b 294 (21.2) 136 (20.5)
Non-Stroke Belt c 565 (40.8) 2575 (46.5)
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Table 1. Cont.
Sepsis Cases (n =1386) Non-Sepsis Controls * (n = 5544) p Value **
Temperature 30-Day Mean (◦F) € 59.5 (48.6–65.5) 59.1 (47.4–72.8) <0.01
Temperature 365-Day Mean (◦F) € 62.4 (56.7–65.7) 61.9 (54.9–65.6) 0.03
Season 1.0
Fall 301 (21.7) 1204 (21.7)
Spring 371 (26.8) 1484 (26.8)
Summer 309 (22.3) 1236 (22.3)
Winter 405 (29.2) 1620 (29.2)
Urbanicity (%)
Mixed 455 (32.9) 1582 (28.6) <0.01
Rural 84 (6.1) 278 (5.0)
Urban 844 (61.0) 3670 (61.0)
Tobacco Use (%)
Never 485 (35.2) 2539 (46.0) <0.01
Past 648 (47.0) 2364 (42.8)
Current 245 (17.8) 619 (11.2)
Alcohol Use (%)
Never 916 (67.5) 3341(61.4)) <0.01
Past 390 (28.7) 1846 (34.0)
Current 52 (3.8) 251 (4.6)
Baseline Medical Condition (%)
Atrial fibrillation 185 (13.6) 499 (9.2) <0.01
Chronic lung disease 263 (19.0) 453 (8.2) <0.01
Coronary artery disease 390 (28.9) 1089 (20.0) <0.01
Deep vein thrombosis 114 (8.3) 295 (5.3) <0.01
Diabetes 447 (32.3) 1163 (21.0) <0.01
Dyslipidemia 865 (65.1) 3242 (60.4)) <0.01
Hypertension 945 (68.5) 3261 (59.0) <0.01
Myocardial infarction 279 (20.6) 760 (14.0) <0.01
Obesity 846 (61.2) 2718 (49.1) <0.01
Peripheral artery disease 64 (4.6) 94 (1.7) <0.01
Stroke 150 (10.9) 347 (6.3) <0.01
* Matched for age, sex, and race, † Mean (Standard deviation), € Median (IQR); ** Estimated using conditional
logistic regression (Wald test) or paired t-test. a Stroke Buckle (coastal plains of North Carolina, South Carolina,
and Georgia). b Stroke Belt (remainder of North Carolina, South Carolina and Georgia, plus Tennessee, Mississippi,
Alabama, Louisiana, and Arkansas). c Non-Belt/Buckle (other states).
Mean PM2.5 exposure levels were similar between cases and controls at 30 days (Cases: 12.44
(SD 3.13) vs. Controls: 12.34 (3.02) µg/m3; p = 0.28) and one-year (Cases: 12.53 (1.73) vs. Controls:
12.50 (1.73) µg/m3; p = 0.66) (Figure 2).
When examining the associations between preceding 30-day PM2.5 exposure and sepsis, higher
PM2.5 levels were not associated with adjusted odds of sepsis (2nd vs. 1st quartile OR 0.93 [95% CI:
0.76–1.14]; 3rd vs. 1st quartile OR 0.86 [95% CI: 0.70–1.05]; 4th vs. 1st quartile OR 1.06 [95% CI:
0.85–1.32]) (Table 2).
When examining the associations between preceding one-year mean PM2.5 and sepsis, higher
levels of PM2.5 were not associated with odds of sepsis, even after adjustment for potential confounders
(2nd vs. 1st quartile OR 0.99 [95% CI: 0.82–1.21]; 3rd vs. 1st quartile OR 1.04 [95% CI: 0.85–1.27]; 4th vs.
1st quartile OR 0.96 [95% CI: 0.78–1.18]).
We observed similar results when limiting the analysis to respiratory-infection-related sepsis
events only (Appendix A Table A2).
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Figure 2. Distribution of average daily mean particulate values for 30-day preceding sepsis case event
among 6906 cases and controls.
Table 2. Odds ratios * (ORs) and associated 95% confidence intervals (CIs) for the association between
the preceding 30-day and one-year mean particulate matter 2.5 and incident sepsis. Among 1386 sepsis
cases and 5544 controls matched on age (±5 years), race, and sex.
Unadjusted Model 1 a Model 2 b Model 3 c
Preceding 30-Day Mean OR (95% CI)
Particulate Matter 2.5
Per SD µg/m3 increase
(SD** = 3.04)
1.06 (0.98, 1.13) 1.04 (0.96, 1.12) 1.03 (0.96, 1.11) 1.04 (0.96, 1.13)
p-value 0.13 0.32 0.40 0.36
Particulate Matter 2.5
1st Quartile (3.27–10.53 µg/m3) Referent Referent Referent Referent
2nd Quartile (10.53–11.97 µg/m3) 1.05 (0.88, 1.25) 0.98 (0.82, 1.17) 0.98 (0.82, 1.18) 0.93 (0.76, 1.14)
3rd Quartile (11.97–13.78 µg/m3) 0.97 (0.82, 1.16) 0.91 (0.76, 1.09) 0.90 (0.75, 1.09) 0.86 (0.70, 1.05)
4th Quartile (13.78–28.11 µg/m3) 1.14 (0.94, 1.38) 1.09 (0.89, 1.32) 1.08 (0.88, 1.32) 1.06 (0.85, 1.32)
p-valuetrend 0.36 0.31 0.31 0.22
Preceding One-Year Mean OR (95% CI)
Particulate Matter 2.5
Per SD µg/m3 increase
(SD** = 1.73)
1.03 (0.96, 1.09) 0.99 (0.92, 1.06) 0.98 (0.92, 1.05) 0.98 (0.91, 1.05)
p-value 0.45 0.71 0.59 0.56
Particulate Matter 2.5
1st Quartile (5.88–11.48 µg/m3) Referent Referent Referent Referent
2nd Quartile (11.48–12.58 µg/m3) 1.10 (0.93, 1.30) 1.00 (0.84, 1.19) 0.99 (0.82, 1.18) 0.99 (0.82, 1.21)
3rd Quartile (12.58–13.53 µg/m3) 1.15 (0.97, 1.36) 1.05 (0.88, 1.26) 1.05 (0.87, 1.26) 1.04 (0.85, 1.27)
4th Quartile (13.53–20.18 µg/m3) 1.10 (0.92, 1.32) 1.00 (0.83, 1.21) 0.98 (0.81, 1.26) 0.96 (0.78, 1.18)
p-valuetrend 0.44 0.92 0.88 0.87
* Estimated using Conditional Logistic Regression. ** Standard Deviation (SD). a Additionally adjusted education,
income, region, temperature (30-day or 365 depending on pollution exposure), and urbanicity. b Additionally
adjusted for tobacco and alcohol use. c Additionally adjusted for baseline health conditions.
4. Discussion
In this study, we observed no associations between 30-day and one-year PM2.5 exposure and
future risk of odds of community-acquired sepsis. Prior studies have linked air pollution with the
risk of infections and other medical conditions. For example, in a 2009 case-control study Neupane
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et al. reported that among individuals aged 65 years or older, there was a 2-fold increased risk of
hospitalization for community-acquired pneumonia in those exposed to elevated levels of ambient
nitrogen and PM2.5 [7]. Further, a recent meta-analysis by Brook et al. concluded that PM2.5 exposure
can prompt cardiovascular disease and that long-term exposure may increase the risk for cardiovascular
mortality. Brook et al. also concluded that decreased life expectancy could be attributed to PM2.5 in
highly exposed populations [3]. Lastly, in a 2004 cohort study, Pope et al. examined PM2.5 exposure
and the risk of mortality related to cardiovascular conditions, including ischemic heart disease,
dysrhythmias, hypertension, atherosclerosis, and diabetes. Pope et al. reported that individuals
with increased PM2.5 exposure had an elevated risk of mortality from combined cardiovascular causes
plus diabetes (OR 1.12 [95% CI: 1.08–1.15) [9].
We originally hypothesized that PM2.5 exposure would be linked with sepsis risk due to the known
associations of particulate matter exposure with infection risk and induction of cardiopulmonary
toxicity [23]. It is plausible that other environmental factors were not accounted for in our analysis.
For example, other environmental exposures such as solar insulation or geographical altitude could
have contributed to the observed effects of particulate matter on sepsis risk. Individuals living
at higher attitudes may have had lower PM2.5 tolerance due to lower atmospheric oxygenation.
Most importantly, our study used U.S. data. Exposure patterns and associations may differ in other
countries with varying populations, pollution sources and climate. Future studies may consider
prospective pollution measurements obtained from on-person or in-home air quality monitors.
After controlling for potential risk factors for sepsis such as multiple baseline medical conditions,
alcohol use, and tobacco use, there were no significant differences. However, our prior studies have
identified a number of individual level risk factors strongly associated with sepsis among community
dwelling adults [10,24,25]. The overarching aim of these studies is to identify opportunity to prevent or
reduce long-term sepsis risk. We previously identified regional variations in sepsis mortality. Regional
variations may be due to a range of factors including geographic similarities in comorbid burden,
healthcare quality and environmental exposures. Given the geographic similarities between U.S. sepsis
mortality and PM2.5 patterns, we expected that PM2.5 environment exposure might alter sepsis risk.
However, the data from this research does not support this supposition. Efforts to reduce community
sepsis risk should focus on other factors.
Limitations
The REGARDS-sepsis cohort provides the unique opportunity to examine the risk of sepsis after
exposure to community-level fine particulate matter exposure among a cohort of community-dwelling
adults; however, the results of this analysis should be interpreted with a few limitations in mind. First,
the original REGARDS cohort relied upon participant self-report of hospital admission within the
past six months. Therefore, it is plausible that due to non-differential misclassification we observed
an underestimate of the true number of sepsis cases. A future study should aim to prospectively
examine sepsis cases among a large nationally representative sample of community-dwelling adults.
The REGARDS cohort included participants 45 and older at baseline and therefore the results of this
study are not generalizable to the younger U.S. adult population. In addition, the PM2.5 data in this
analysis were based upon a combination of satellite and ground-level data; different observations
may have resulted from direct PM2.5 sampling. Measured particulate matter exposure may not
represent the participants’ physiological exposure. REGARDS is a national cohort but not nationally
representative. The participants’ baseline geocoded residences may not reflect an accurate estimate
of individual particulate matter exposure due to the possibility of the participants’ non-residential
environments. Participant migration may have altered the assumed PM2.5 exposures. Nevertheless,
to our knowledge no prior study has evaluated the associations between sepsis and air pollution.
In addition, our study provides great generalizability and addresses a gap within the research literature
because we utilized one of the largest United States population-based cohorts complemented with
NASA national particulate matter data.
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5. Conclusions
In the REGARDS cohort, PM2.5 air pollution exposure was not associated with odds of sepsis.
While we identified no association between air pollution and sepsis, future studies should aim to
assess individual-level air pollution exposure with time-varying measurements.
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Appendix A
Table A1. Detailed definitions and technical information for sociodemographics, health behaviors,
and chronic medical conditions.
Characteristics Definition and/or Technical Information
Sociodemographics
Age Age in years
Gender Male; female
Race African-American; white
Education Participant reported:
- Less than high school
- High school graduate
- Some college
- College or higher
- Missing
Income Participant reported:
- <$20 k
- $20–$34K
- $35–$74K
- ≥$75K
- Missing (not reported)
Geographic Region Participant residence:
- Stroke Buckle (coastal plains of North Carolina, South Carolina, and Georgia)
- Stroke Belt (remainder of North Carolina, South Carolina, and Georgia, plus
Tennessee, Mississippi, Alabama, Louisiana, and Arkansas)
- Non-Belt/Buckle (other states)
Health Behaviors
Smoking Status Participant reported:
- Current
- Past
- Never
Alcohol use Participant reported:
- None
- Moderate (up to one drink per day for women or two drinks per day for men)
- Heavy (>1 drink per day for women and >2 drinks per day for men) [26].
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Table A1. Cont.
Characteristics Definition and/or Technical Information
Chronic Medical Conditions
Atrial Fibrillation Participant reported history of atrial fibrillation.
Chronic Lung Disease Participant use of pulmonary medications (beta agonists, leukotriene inhibitors, inhaled
corticosteroids, combination inhalers, ipratropium, cromolyn, aminophylline and
theophylline) as a surrogate for chronic lung disease.
Coronary Artery Disease Participant reported history of myocardial infarction, coronary artery bypass grafting, or
cardiac angioplasty or stenting, or baseline electrocardiographic evidence of myocardial
infarction.
Diabetes Fasting glucose ≥126 mg/L (or a glucose ≥200 mg/L for those not fasting) or participant
reported use of insulin or oral hypoglycemic agents.
Deep Vein Thrombosis Participant reported history of deep vein thrombosis.
Dyslipidemia Low-density lipoprotein cholesterol >130 mg/dL or participant reported use of lipid
lowering medications.
Hypertension Systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or
participant reported antihypertensive agent use.
Myocardial Infarction Participant reported history of myocardial infarction or baseline electrocardiographic
evidence of myocardial infarction.
Obesity {Waist circumference [>102 cm for males or >88 cm for females]} or {body mass index
≥30 kg/m2}.
Peripheral Artery Disease Participant reported history of lower extremity arterial bypass or leg amputation.
Stroke Participant reported history of stroke or transient ischemic attack.
Table A2. Odds ratios * (ORs) and associated 95% confidence intervals (CIs) for the association between
the preceding 30-day and one-year mean particulate matter 2.5 and incident respiratory infection
related sepsis. Among 776 total events.
Unadjusted Model 1 a Model 2 b Model 3 c
Preceding 30-Day Mean OR (95% CI)
Particulate Matter 2.5
Per SD µg/m3 increase
(SD** = 3.04)
1.01 (0.91, 1.12) 0.99 (0.89, 1.11) 1.00 (0.90, 1.12) 0.99 (0.87, 1.12)
p-value 0.87 0.90 0.98 0.84
Particulate Matter 2.5
1st Quartile (3.27–10.53 µg/m3) Referent Referent Referent Referent
2nd Quartile (10.53–11.97 µg/m3) 1.18 (0.93, 1.49) 1.12 (0.88, 1.43) 1.16 (0.90, 1.49) 1.16 (0.87, 1.54)
3rd Quartile (11.97–13.78 µg/m3) 0.91 (0.71, 1.17) 0.85 (0.65, 1.10) 0.87 (0.66, 1.14) 0.85 (0.63, 1.14)
4th Quartile (13.78–28.11 µg/m3) 1.06 (0.81, 1.40) 1.04 (0.78, 1.38) 1.09 (0.81, 1.47) 1.04 (0.75, 1.42)
p-valuetrend 0.17 0.16 0.13 0.18
Preceding One-Year Mean OR (95% CI)
Particulate Matter 2.5
Per SD µg/m3 increase (SD** =
1.73)
1.02 (0.94, 1.12) 0.99 (0.90, 1.09) 0.99 (0.90, 1.09) 0.98 (0.88, 1.09)
p-value 0.62 0.80 0.78 0.67
Particulate Matter 2.5
1st Quartile (5.88–11.48 µg/m3) Referent Referent Referent Referent
2nd Quartile (11.48–12.58 µg/m3) 1.00 (0.79, 1.26) 0.91 (0.71, 1.17) 0.87 (0.67, 1.13) 0.83 (0.62, 1.11)
3rd Quartile (12.58–13.53 µg/m3) 1.02 (0.80, 1.29) 0.92 (0.72, 1.19) 0.95 (0.73, 1.23) 0.92 (0.68, 1.23)
4th Quartile (13.53–20.18 µg/m3) 1.03 (0.80, 1.32) 0.93 (0.72, 1.22) 0.91 (0.69, 1.20) 0.85 (0.63, 1.16)
p-valuetrend 1.00 0.89 0.77 0.60
* Estimated using Conditional Logistic Regression. ** Standard Deviation (SD). a Additionally adjusted education,
income, region, temperature (30-day or 365 depending on pollution exposure), and urbanicity. b Additionally
adjusted for tobacco and alcohol use. c Additionally adjusted for baseline health conditions.
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